Sanofi stock slips 0.42% to EUR 83.73 before Xetra open
Published on 11/05/2026 at 08:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat investors should watch
- Sanofi reported double-digit growth in third-quarter 2026 sales and business earnings per share.
- Management upgraded its full-year 2026 guidance on October 30.
- The next listed investor event is the Wolfe Research Healthcare Conference on November 10 in New York.
Sanofi stock traded at EUR 83.73 on Lang & Schwarz at 08:40 CET on Thursday, November 5, 2026, 0.42 percent below the Xetra close of Wednesday, November 4, at EUR 84.08.
The French pharmaceutical group enters the session after reporting double-digit growth in third-quarter 2026 sales and business earnings per share. Management also upgraded its full-year 2026 guidance on October 30, according to the Sanofi investor relations page.
The update keeps execution against the revised annual targets at the center of the investment case. The company has listed the Wolfe Research Healthcare Conference in New York for November 10, followed by healthcare-sector investor events in London and Boston later in the month.
Investors can follow the real-time quote of Sanofi stock during the session.
The CAC 40 provides the relevant French market backdrop for the session.
